Hancock Jaffe Laboratories- Warrants (30/05/2023) Receivables

As of the most recent data (June 2026), HJLIW shows a receivables of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, HJLIW's receivables is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Hancock Jaffe Laboratories- Warrants (30/05/2023) is outperforming or lagging.

Tracking HJLIW's receivables over time shows whether Hancock Jaffe Laboratories- Warrants (30/05/2023) is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Hancock Jaffe Laboratories- Warrants (30/05/2023)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $0) with ownership activity and broader fundamentals.

Hancock Jaffe Laboratories- Warrants (30/05/2023)'s receivables is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.